Recent publications
Article
Greenman, R, Segal-Salto, M, Barashi, N, Hay, O, Katav, A, Levi, O, Vaknin, I, Aricha, R, Aharoni, S, Snir, T, Mishalian, I, Olam, D, Amer, J, Salhab, A, Safadi, R, Maor, Y, Trivedi, P, Weston, CJ, Saffioti, F, Hall, A, Pinzani, M, Thorburn, D, Peled, A & Mor, A 2023, 'CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis', JCI Insight, vol. 8, no. 12, e162270. https://doi.org/10.1172/jci.insight.162270
ESOT Guidelines Taskforce 2023, 'Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement', Transplant international, vol. 36, 11729. https://doi.org/10.3389/ti.2023.11729
IAIHG and EASL DHILI Consortium 2023, 'Nomenclature, Diagnosis and Management of Drug-induced Autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report', Journal of Hepatology. https://doi.org/10.1016/j.jhep.2023.04.033
Mayo, MJ, Vierling, JM, Bowlus, CL, Levy, C, Hirschfield, GM, Neff, GW, Galambos, MR, Gordon, SC, Borg, BB, Harrison, SA, Thuluvath, PJ, Goel, A, Shiffman, ML, Swain, MG, Jones, DEJ, Trivedi, P, Kremer, AE, Aspinall, RJ, Sheridan, DA, Dörffel, Y, Yang, K, Choi, YJ & McWherter, CA 2023, 'Open‐label, clinical trial extension: Two‐year safety and efficacy results of seladelpar in patients with primary biliary cholangitis', Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.17755
Abbas, N, Culver, EL, Thorburn, D, Halliday, N, Crothers, H, Dyson, JK, Phaw, A, Aspinall, R, Khakoo, SI, Kallis, Y, Smith, B, Patanwala, I, McCune, A, Chimakurthi, CR, Hegade, V, Orrell, M, Jones, R, Mells, G, Thain, C, Thain, R-M, Jones, D, Hirschfield, G & Trivedi, PJ 2023, 'UK-Wide Multicenter Evaluation of Second-line Therapies in Primary Biliary Cholangitis', Clinical Gastroenterology and Hepatology, vol. 21, no. 6, pp. 1561-1570.e13. https://doi.org/10.1016/j.cgh.2022.07.038
UK-PBC audit collaborators 2022, 'The national audit of primary biliary cholangitis (PBC) in the United Kingdom: defining the audit dataset and data collection system', Cureus, vol. 14, no. 6, e25609. https://doi.org/10.7759/cureus.25609
Trivedi, PJ, Crothers, H, Mytton, J, Bosch, S, Iqbal, T, Ferguson, J & Hirschfield, GM 2020, 'Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel diseases, based on sex, race, and age', Gastroenterology, vol. 159, no. 3, pp. 915-928. https://doi.org/10.1053/j.gastro.2020.05.049
International Primary Sclerosing Cholangitis Study Group (IPSCSG) 2020, 'Effects of vedolizumab in patients with primary sclerosing cholangitis and inflammatory bowel diseases', Clinical Gastroenterology and Hepatology, vol. 18, no. 1, pp. 179-187.e6. https://doi.org/10.1016/j.cgh.2019.05.013
Global PBC Study Group 2020, 'Goals of treatment for improved survival in primary biliary cholangitis: treatment target should be bilirubin within the normal range and normalization of alkaline phosphatase', The American Journal of Gastroenterology, vol. 115, no. 7, pp. 1066-1074. https://doi.org/10.14309/ajg.0000000000000557
Trivedi, PJ, Muir, AJ, Levy, C, Bowlus, CL, Manns, M, Lu, X, Crans, G, Chung, C, Subramanian, GM, Myers, RP, Goodman, Z, Chalasani, N, Vierling, JM, Guha, IN & Hirschfield, GM 2020, 'Inter- and intra-individual variation, and limited prognostic utility, of serum alkaline phosphatase in a trial of patients with primary sclerosing cholangitis', Clinical Gastroenterology and Hepatology, vol. 2020. https://doi.org/10.1016/j.cgh.2020.07.032
Global PBC Study Group 2020, 'Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis', Journal of Hepatology, vol. 73, no. 3, pp. 559-565. https://doi.org/10.1016/j.jhep.2020.03.043
Chapman, RW, Aspinall, RJ, Trivedi, P, Wright, G & Heneghan, M 2019, 'Challenges in the use of corticosteroids in the management of autoimmune hepatitis', British journal of hospital medicine, vol. 80, no. 10, pp. 594-599. https://doi.org/10.12968/hmed.2019.80.10.594
Global PBC Study Group 2019, 'Effects of age and sex of response to ursodeoxycholic acid and transplant-free survival in patients with primary biliary cholangitis', Clinical Gastroenterology and Hepatology, vol. 17, no. 10, pp. 2076-2084.e2. https://doi.org/10.1016/j.cgh.2018.12.028
UK-PSC Consortium 2019, 'Factors associated with outcomes of patients with primary sclerosing cholangitis and development and validation of a risk scoring system', Hepatology, vol. 69, no. 5, pp. 2120-2135. https://doi.org/10.1002/hep.30479
Review article
Ricciuto, A, Kamath, BM, Hirschfield, GM & Trivedi, PJ 2023, 'Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: A coming of age or an age-ist problem?', Journal of Hepatology, vol. 79, no. 2, pp. 567-575. https://doi.org/10.1016/j.jhep.2023.02.030
View all publications in research portal